Corridor · Sourcing Intelligence
Akunudo screens manufacturers of Insulin Glargine 100IU/ml for Saudi Arabia registration before you ever see them — certification, stability zone for the climate, and dossier format clear first; commercial fit second. Identities stay sealed until NDA, so you can source without tipping your hand.
No manufacturer in the corridor matches this exact spec for Saudi Arabia right now.
Submit a mandate and we'll match it the moment a qualified manufacturer enters the corridor — and alert you.
Not a directory to wade through — a brokered, anonymized corridor. We only fully win when your deal closes.
Market access · Saudi Arabia
eCTD registration via the eSDR system with pre-pricing before submission. A Verification/Abridged reliance pathway (~60 working days) fast-tracks products already approved by FDA or EMA. SFDA sets a ceiling CIF price using external reference pricing against ~16 comparable countries (lowest-in-basket); lifecycle repricing up to ~30%.
SFDA, through the eSDR (SDR) system: company registration → product registration → pricing.
eCTD — mandatory electronic submission.
Yes — an authorized local representative / agent in Saudi Arabia.
Yes — the Verification & Abridged pathway: an abridged ~60-working-day review when the product is already approved by a recognized reference agency (US FDA or EMA), submitted within 2 years of that approval, with the manufacturer located in a recognized country list. Standard products can also use priority review.
A GMP assessment is required, but the on-site inspection may be WAIVED where the site is already approved by recognized authorities or under GCC frameworks.
Orientation intelligence compiled from public regulator and analyst sources as of the dates shown — not legal or regulatory advice. Rules change; confirm specifics (fees, timelines, baskets, eligibility) with the authority before acting. (Authority: SFDA — Saudi Food & Drug Authority (eSDR / SDR system); as of 2026-06.)